A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
Clinical trial NCT06266143 · COMPLETED
Trial details
- NCT number
- NCT06266143
- Sponsor
- Wuhan YZY Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-08
- Primary completion
- 2025-01-21
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.